Name | tert-butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate |
---|---|
Synonyms |
2-Methyl-2-propanyl 4-(2-cyano-4-nitrophenyl)-1-piperazinecarboxylate
1-Piperazinecarboxylic acid, 4-(2-cyano-4-nitrophenyl)-, 1,1-dimethylethyl ester 5-nitro-2-(4-tert-butoxycarbonylpiperazin-1-yl)benzonitrile 4-(2-cyano-4-nitro-phenyl)-piperazine-1-carboxylic acid tert-butyl ester |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 499.1±45.0 °C at 760 mmHg |
Molecular Formula | C16H20N4O4 |
Molecular Weight | 332.354 |
Flash Point | 255.7±28.7 °C |
Exact Mass | 332.148468 |
PSA | 102.39000 |
LogP | 1.93 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.591 |
HS Code | 2933599090 |
---|
~88% 288251-87-6 |
Literature: Nozulak, Joachim; Orain, David; Cotesta, Simona Patent: US2009/99199 A1, 2009 ; Location in patent: Page/Page column 17-18 ; |
~% 288251-87-6 |
Literature: Mitsubishi Pharma Corporation Patent: EP1176140 A1, 2002 ; Location in patent: Page 57 ; |
Precursor 4 | |
---|---|
DownStream 1 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |